Clinical experience with eperisone in the treatment of acute low back pain

Minerva Medica

Volumn 99, Issue 4, 2008, Pages 347-352

  Beltrame, A ^a   Grangie S ^b   Guerra, L ^c  

^a Legnago Hospital   (Italy)

^b Ospedale Piccole Figlie   (Italy)

^c Medical Service   (Italy)

Author keywords

Eperisone; Low back pain; Muscle, skeletal

Indexed keywords

EPERISONE;

ADULT; AGED; ANALGESIC ACTIVITY; ARTICLE; BACK MUSCLE; COGNITIVE DEFECT; DROWSINESS; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG WITHDRAWAL; EPIGASTRIC PAIN; FEMALE; FOLLOW UP; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MUSCLE RELAXATION; MUSCLE RIGIDITY; MUSCLE SPASM; MYALGIA; NAUSEA; NOCICEPTION; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PASSIVE MOVEMENT; PHYSICAL EXAMINATION; TREATMENT DURATION;

ADULT; AGED; ANALYSIS OF VARIANCE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE RELAXANTS, CENTRAL; PROPIOPHENONES; SPASM;

EID: 52449100899     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Church EJ, Odle TG. Diagnosis and treatment of back pain. Radiol Technol 2007;79:126-51.
2. Ehrlich GE. Back pain. J Rheumatol Suppl 2003;67:26-31.
3. Fassina A, Rubinacci A, Tessari L. Muscular contracture as a component of low back pain: evaluation criteria and significance of relaxant therapy. Int J Clin Pharmacol Res 1986;6:501-7.
4. Colloca CJ, Keller TS. Stiffness and neuromuscular reflex response of the human spine to posteroanterior manipulative thrusts in patients with low back pain. J Manipulative Physiol Ther 2001;24:489-500.
5. Mense S. Neurobiological basis for the use of botulinum toxin in pain therapy. J Neurol 2004;251 (Suppl 1):I1-7.
6. Claude LN, Solomonow M, Zhou BH, Baratta RV, Zhu MP. Neuromuscular dysfunction elicited by cyclic lumbar flexion. Muscle Nerve 2003;27:348-58.
7. Sbriccoli P, Yousuf K, Kupershtein I, Solomonow M, Zhou BH, Zhu MP et al. Static load repetition is a risk factor in the development of lumbar cumulative musculoskeletal disorder. Spine 2004;29:2643-53.
8. Solomonow M, Baratta RV, Zhou BH, Burger E, Zieske A, Gedalia A. Muscular dysfunction elicited by creep of lumbar viscoelastic tissue. J Electromyogr Kinesiol 2003;13:381-96.
9. Williams M, Solomonow M, Zhou BH, Baratta RV, Harris M. Multifidus spasms elicited by prolonged lumbar flexion. Spine 2000;25:2916-24.
10. Malanga GA, Dennis RL. Use of medications in the treatment of acute low back pain. Clin Occup Environ Med 2006;5:643-53.
11. Deyo RA. Drug therapy for back pain. Which drugs help which patients? Spine 1996;21:2840-9.
12. Chou R, Huffman LH, American Pain Society, American College of Physicians. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med 2007;147:505-14.
13. van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM, Cochrane Back Review Group. Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the Cochrane collaboration. Spine 2003;28:1978-92.
14. Kocsis P, Farkas S, Fodor L, Bielik N, Thán M, Kolok S et al. Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels. J Pharmacol Exp Ther 2005;315:1237-46.
15. Nakagawa M, Nakahara K, Maruyama Y, Kawabata M, Higuchi I, Kubota H et al. Therapeutic trials in 200 patients with HTLV-1-associated myelopathy/ tropical spastic paraparesis. J Neurovirol 1996;2:345-55.
16. Murayama K, Katsumi T, Tajika E, Nakamura T. Clinical application of eperisone hydrochloride to neurogenic bladder. Hinyokika Kiyo 1984;30:403-8.
17. Tariq M, Akhtar N, Ali M, Rao S, Badshah M, Irshad M. Eperisone compared to physiotherapy on muscular tone of stroke patients: a prospective randomized open study. J Pak Med Assoc 2005;55:202-4.
18. Kobayashi Y, Kawasaki T, Yoshimi T, Nakajima T, Kanai K. Muscle cramps in chronic liver diseases and treatment with antispastic agent (eperisone hydrochloride). Dig Dis Sci 1992;37:1145-6.
19. Tanaka K, Kaneko T, Yamatsu K. Effects of 4′-ethyl-2-methyl-3- piperidinopropriophenone on experimental rigidity and spinal cord activity. Folia Pharmacol Japon 1981;77:511-20.
20. Mano T, Miyaoka T Effects of muscle relaxant E.M.P.P. on afferent discharges of muscle spindle in man: an microneurographic analysis. No To Shinkei 1981;33:237-41.
21. Inoue S, Bian K, Okamura T, Okunishi H, Toda N. Mechanisms of action of eperisone on isolated dog saphenous arteries and veins. Jpn J Pharmacol 1989;50:271-82.
22. van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev 2003;(2):CD004252.
23. Toth PP, Urtis J. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone. Clin Ther 2004;26:1355-67.